Literature DB >> 6020853

Antihaemophilic globulin: preparation by an improved cryoprecipitation method and clinical use.

D L Brown, R M Hardisty, M H Kosoy, C Bracken.   

Abstract

Mesh:

Substances:

Year:  1967        PMID: 6020853      PMCID: PMC1841274          DOI: 10.1136/bmj.2.5544.79

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  9 in total

1.  HIGH-POTENCY ANTIHAEMOPHILIC FACTOR CONCENTRATE PREPARED FROM CRYOGLOBULIN PRECIPITATE.

Authors:  J G POOL; E J GERSHGOLD; A R PAPPENHAGEN
Journal:  Nature       Date:  1964-07-18       Impact factor: 49.962

2.  The survival of factor VIII (antihemophilic globulin) and factor IX (plasma thromboplastin component) in normal humans.

Authors:  E ADELSON; J J RHEINGOLD; O PARKER; M STEINER; J C KIRBY
Journal:  J Clin Invest       Date:  1963-07       Impact factor: 14.808

3.  THE FATE OF PROTHROMBIN AND FACTORS VIII, IX AND X TRANSFUSED TO PATIENTS DEFICIENT IN THESE FACTORS.

Authors:  R BIGGS; K W DENSON
Journal:  Br J Haematol       Date:  1963-10       Impact factor: 6.998

4.  THE IN VIVO LONGEVITY OF ANTIHAEMOPHILIC FACTOR (FACTOR VIII).

Authors:  C F ABILDGAARD; J A CORNET; E FORT; I SCHULMAN
Journal:  Br J Haematol       Date:  1964-04       Impact factor: 6.998

5.  A one-stage factor VIII (antihaemophilic globulin) assay and its use on venous and capillary plasma.

Authors:  R M HARDISTY; J C MACPHERSON
Journal:  Thromb Diath Haemorrh       Date:  1962-05-15

6.  The determination of plasma fibrinogen by the clot-weight method.

Authors:  I C INGRAM
Journal:  Biochem J       Date:  1952-08       Impact factor: 3.857

7.  Production of high-potency concentrates of antihemophilic globulin in a closed-bag system.

Authors:  J G Pool; A E Shannon
Journal:  N Engl J Med       Date:  1965-12-30       Impact factor: 91.245

8.  The treatment of classical hemophilia with cryoprecipitates. Laboratory control with readily available tests.

Authors:  P G Hattersley
Journal:  JAMA       Date:  1966-10-17       Impact factor: 56.272

9.  FURTHER EXPERIENCE IN USE OF HUMAN ANTIHAEMOPHILIC GLOBULIN (H.A.H.G.) FOR THE CONTROL OF BLEEDING AFTER DENTAL EXTRACTION IN HAEMOPHILIC PATIENTS: A REPORT TO THE MEDICAL RESEARCH COUNCIL'S WORKING PARTY ON HUMAN ANTIHAEOMOPHILIC GLOBULIN.

Authors:  R BIGGS; B M RUSH; R G MACFARLANE; J M MATTHEWS; F C JOHNSTONE; D S HAYTON-WILLIAMS
Journal:  Lancet       Date:  1965-05-08       Impact factor: 79.321

  9 in total
  7 in total

1.  A biological standard for measurement of blood coagulation Factor VIII activity.

Authors:  D R Bangham; R Biggs; M Brozović; K W Denson; J L Skegg
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

2.  Cryoprecipitate and the use of the plastic blood bag system in the management of haemophilia and other coagulation disorders.

Authors:  K M Dormandy
Journal:  Proc R Soc Med       Date:  1968-06

3.  Intracranial ventricular haemorrhage as a first presentation of haemophilia. A case of successful surgical management.

Authors:  A Adeloye; O Seriki; L Luzzatto; E M Essien
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-10       Impact factor: 10.154

4.  Comparison of qucik and slow thaw methods of producing cryoprecipitate antihaemophilic factor from fresh and 24-hour-old blood.

Authors:  A L Bloom; J C Giddings; B Bevan; M Letton; R J Drummond
Journal:  J Clin Pathol       Date:  1969-07       Impact factor: 3.411

5.  Studies on the procurement of blood coagulation factor VIII: effects of plasma freezing rate and storage conditions on cryoprecipitate quality.

Authors:  A Farrugia; C Prowse
Journal:  J Clin Pathol       Date:  1985-04       Impact factor: 3.411

6.  Cryoprecipitate and the plastic blood-bag system: provision of adequate replacement therapy for routine treatment of haemophilia.

Authors:  E Bennett; K M Dormandy; W G Churchill; A R Coward; M Smith; T E Cleghorn
Journal:  Br Med J       Date:  1967-04-08

7.  Hip arthroplasty in a haemophiliac and subsequent prophylactic therapy with cryoprecipitate.

Authors:  A Bellingham; D Fletcher; E O Kirwan; T A Prankerd; T Cleghorn
Journal:  Br Med J       Date:  1967-12-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.